Picture of Inogen logo

INGN — Inogen News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousSmall CapSuper Stock

Inogen Inc expected to post a loss of 59 cents a share - Earnings Preview

* Inogen Inc  INGN.OQ   INGN.O  is expected to show a fall
in
quarterly revenue when it reports  results on August 7. 
    * The Goleta California-based  company is expected to report
 a
10.8% decrease in revenue to $92.2 million from $103.38 million
a year ago, according to the mean estimate from 5 analysts,
based on Refinitiv data. The company's guidance on July 13 2023,
for the period ended June 30, was for revenue between $83.00
million and $84.00 million.
    * ​Refinitiv's mean analyst estimate for Inogen Inc is for a
loss
of 59 cents per share. 
    * The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is no "strong buy" or "buy," 5
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Inogen Inc
is
$15​, above​ its last closing price of $7.59. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Mar. 31 2023  -0.82       -0.81      -0.88     Missed  -8.3
 Dec. 31 2023  -0.56       -0.57      -0.20     Beat    65.2
 Sep. 30 2022  -0.42       -0.42      -0.42     Met     -0.2​
 Jun. 30 2022  -0.37       -0.37      -0.15     Beat    59.5
 ​​Mar.        -0.52       -0.51      -0.62     Missed  -21.8
 31 2022                                                
 Dec. 31 2021  -0.72       -0.73      -1.01     Missed  -38.6​
 Sep. 30 2021  -0.31       -0.26      0.53      Beat    303.8
 Jun. 30 2021  -0.10       -0.11      0.22      Beat    300
 This summary was machine generated August 5 at 02:16 GMT.  All
figures in US dollars  unless otherwise stated

Recent news on Inogen

See all news